Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance

Kim Hee Kyung; Kang Wonseok; Sinn Dong Hyun; Lee Joon Hyeok; Kim Won Seog; Kim Seok Jin

首页> 外文期刊>Trends in Ecology & Evolution >Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance

【24h】

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance

机译：含有利妥昔单抗免疫化治疗和利妥昔单抗维持治疗的滤泡淋巴瘤患者的真实数据

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Aims: Real-world data about the treatment outcomes of patients receiving rituximab-containing immunochemotherapy followed by rituximab maintenance are required to understand better the treatment for follicular lymphoma (FL).

机译：背景技术：关于接受含生花草免疫化学疗法的患者的治疗结果的现实数据是需要Rituximab维持的方法，以了解滤泡淋巴瘤（FL）的治疗方法。

著录项

来源
《Trends in Ecology & Evolution 》 |2020年第1期| 共12页
作者
Kim Hee Kyung; Kang Wonseok; Sinn Dong Hyun; Lee Joon Hyeok; Kim Won Seog; Kim Seok Jin;
展开▼
作者单位

Chungbuk Natl Univ Hosp Dept Internal Med Cheongju South Korea;

Sungkyunkwan Univ Samsung Med Ctr Dept Med Div Gastroenterol Sch Med Seoul South Korea;

Sungkyunkwan Univ Samsung Med Ctr Dept Med Div Gastroenterol Sch Med Seoul South Korea;

Sungkyunkwan Univ Samsung Med Ctr Dept Med Div Gastroenterol Sch Med Seoul South Korea;

Sungkyunkwan Univ Samsung Med Ctr Dept Med Div Hematol Oncol Sch Med 81 Irwon Ro Seoul 06351 South Korea;

Sungkyunkwan Univ Samsung Med Ctr Dept Med Div Hematol Oncol Sch Med 81 Irwon Ro Seoul 06351 South Korea;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类数学生态学与生物模型 ;
关键词
Lymphoma; follicula; Rituximab; Hepatitis B; Immunochemotherapy;

机译：淋巴瘤;follicula;rituximab;乙型肝炎;免疫细胞疗法;

相似文献

外文文献
中文文献
专利

1. Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance [J] . Hee Kyung Kim, Wonseok Kang, Dong Hyun Sinn, The Korean Journal of Internal Medicine . 2020 ,第1期

机译：含有含有利妥昔单抗免疫化学疗法和利妥昔单抗维持治疗的滤泡淋巴瘤患者的现实数据
2. Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1–3a follicular lymphoma [J] . Bech Rie S., Nielsen Kasper L., Larsen Thomas S., British Journal of Haematology . 2018 ,第2期

机译：1-3A级滤泡淋巴瘤前线免疫化治疗后Rituximab维持治疗的真实数据
3. Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1–3a follicular lymphoma [J] . Bech Rie S., Nielsen Kasper L., Larsen Thomas S., British Journal of Haematology . 2018 ,第2期

机译：1-3A级滤泡性淋巴瘤前线免疫化治疗后Rituximab维持治疗的真实数据
4. Identification of Genes Important in Predicting the Overall Survival in Patients with Follicular Lymphoma [C] . Li Xiao, Kai Fu, Javeed Iqbal, International Conference on Data Mining . 2005

机译：鉴定卵腔淋巴瘤患者总生存的基因重要性
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance [O] . Hee Kyung Kim, Wonseok Kang, Dong Hyun Sinn, 2020

机译：包含利妥昔单抗的免疫化学疗法和利妥昔单抗维持治疗的滤泡性淋巴瘤患者的真实数据
7. Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma [O] . Bech, Rie S, Nielsen, Kasper L, Larsen, Thomas S, 2017

机译：1-3a级滤泡性淋巴瘤一线免疫化疗后利妥昔单抗维持治疗的真实数据

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance

摘要

著录项

相似文献

相关主题

期刊订阅